VEMAVITE-PRX 2 WITH FISH-BASED DHA- ascorbic acid, tribasic calcium phosphate, ferrous fumarate, cholecalciferol, alpha-tocopherol, pyridoxine hydrochloride, folic acid, doconexent and docusate sodium capsule
TRIGEN Laboratories, Inc.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
- 1.25 mg Folic Acid and 300 mg DHA (key omega-3 fatty acid)
- Essential vitamins and minerals
- Gentle stool softener
VemaVite™-PRx 2 is a prescription prenatal/postnatal multivitamin/mineral softgel capsule with fish-based DHA. Each softgel capsule is an oblong, maroon softgel capsule imprinted with “T598″ in white ink.
|Each softgel capsule contains:|
|Vitamin C (ascorbic acid, USP)||28 mg|
|Calcium (tribasic calcium phosphate, NF)||160 mg|
|Iron (ferrous fumarate, USP)||27 mg|
|Vitamin D3 (cholecalciferol, USP)||400 IU|
|Vitamin E (d-alpha tocopherol, USP)||30 IU|
|Vitamin B6 (pyridoxine hydrochloride, USP)||25 mg|
|Folic Acid, USP||1.25 mg|
|DHA (docosahexaenoic acid, contained in the oil derived from fish)||300 mg *|
|Docusate Sodium, USP||55 mg|
Inactive Ingredients: FD&C Blue #1, FD&C Red #40, FD&C Yellow #6, Natural Creamy Orange Flavor, Gelatin, Glycerin, Lecithin, Purified Water, Soybean Oil, Titanium Dioxide, Ethyl Vanillin, Yellow Beeswax.
VemaVite™-PRx 2 softgel capsules are indicated to provide vitamin/mineral and fish-based DHA supplementation throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. VemaVite™-PRx 2 may be useful in improving the nutritional status of women prior to conception.
VemaVite™-PRx 2 is contraindicated in patients with a known hypersensitivity to any of the ingredients, including fish or fish oil. Do not take this product if you are presently taking mineral oil, unless directed by a doctor.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
THIS PRODUCT CONTAINS FISH OIL AND SOY.
Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.
Adverse Reactions to VemaVite-PRx 2 with Fish-Based DHA
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day.
Before, during and/or after pregnancy, one softgel capsule daily or as directed by a physician.
Bottles of 30 softgel capsules.
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
Store at Controlled Room Temperature 20°-25°C (68°-77°F). [See USP].
Call your doctor about side effects. You may report side effects by calling 888 9 TRIGEN (888-987-4436).
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. There are no implied or explicit claims on therapeutic equivalence.
TRIGEN Laboratories, Inc., Sayreville, NJ 08872
MADE IN CANADA
| VEMAVITE-PRX 2
WITH FISH-BASED DHA |
ascorbic acid, tribasic calcium phosphate, ferrous fumarate, cholecalciferol, alpha-tocopherol, pyridoxine hydrochloride, folic acid, doconexent, and docusate sodium capsule
|Labeler — TRIGEN Laboratories, Inc. (830479668)|
Revised: 09/2011 TRIGEN Laboratories, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.